Breaking News

Heat Biologics Appoints SVP of Product Development & Portfolio Strategy

Paul Tebbey is a pharmaceutical development strategy leader with over 25 years of healthcare and management experience.

Author Image

By: Charlie Sternberg

Associate Editor

Heat Biologics Inc., a clinical-stage biopharmaceutical company focused on developing therapies to modulate the immune system, has appointed Paul Tebbey, Ph.D. as senior vice president of Product Development and Portfolio Strategy.   Tebbey is a pharmaceutical development strategy leader with over 25 years of healthcare and management experience across the biotechnology and pharmaceutical sectors at companies such as Abbvie, Baxter, Centocor/Johnson & Johnson and Wyeth/Pfizer.   Tebbey’s...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters